- Contact the Committee

Panel 1 

Honorable James R. Langevin
Member of Congress from the State of Rhode Island 
(Prepared Testimony | PDF)

Panel 2

Nelda P. Wray, MD, MPH
Chief Research and Development Officer
Office of Research and Development
Veterans Health Administration
Department of Veterans Affairs 
(Prepared Testimony | PDF)

Accompanied by: 

Mindy Aisen, MD
Director
Rehabilitation Research and Development 

John G. Demakis, MD
Director
Health Sciences Research and Development 

Fred S. Wright, MD
Associate Chief of Staff for Research
VA Connecticut Healthcare System 

Panel 3 

Eileen Lennon, PhD
Chairman
National Association of Veterans’ Research and Education Foundations 
(Prepared Testimony | PDF)

Accompanied By: 

Ms. Barbara West
Executive Director
National Association of Veterans’ Research and Education Foundations  

Ira R. Katz, MD, PhD
Professor of Psychiatry
Director, Section on Geriatric Psychiatry
University of Pennsylvania Health System 
(Prepared Testimony | PDF)

Kevin C. Dellsperger, MD, PhD
Chief of Staff
Associate Dean for Veterans Affairs
Iowa City VA Medical Center  

Submitting for the Record 

Mr. Christopher Reeve
Christopher Reeve Paralysis Foundation
(Prepared Testimony | PDF)
 

Congressman James R. Langevin of Rhode Island testified before the Subcommittee, acknowledging the importance of VA research.

VA Representatives discussed the development of an oral drug that halts the deadly actions of smallpox in mice at a lab at the San Diego VA Medical Center, as well as other contributions by VA research.

Dr. Eileen Lennon and Ms. Barbara West of the National Association of Veterans’ Research and Education Foundations (NAVREF); Dr. Ira Katz of the University of Pennsylvania Health System; and Dr. Kevin Dellsperger of the Iowa City VA Medical Center discuss the importance of additional funding for VA research.